SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001235010-18-000017
Filing Date
2018-11-07
Accepted
2018-11-07 17:09:00
Documents
65
Period of Report
2018-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q mnta3q201810-q.htm 10-Q 1563340
2 EXHIBIT 31.1 mnta3q201810-qex311.htm EX-31.1 12387
3 EXHIBIT 31.2 mnta3q201810-qex312.htm EX-31.2 12489
4 EXHIBIT 32.1 mnta3q201810-qex321.htm EX-32.1 8593
  Complete submission text file 0001235010-18-000017.txt   8342838

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT mnta-20180930.xml EX-101.INS 2358663
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT mnta-20180930.xsd EX-101.SCH 48920
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT mnta-20180930_cal.xml EX-101.CAL 79949
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT mnta-20180930_def.xml EX-101.DEF 243252
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT mnta-20180930_lab.xml EX-101.LAB 538307
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT mnta-20180930_pre.xml EX-101.PRE 337907
Mailing Address 301 BINNEY STREET CAMBRIDGE MA 02142
Business Address 301 BINNEY STREET CAMBRIDGE MA 02142 617 491-9700
MOMENTA PHARMACEUTICALS INC (Filer) CIK: 0001235010 (see all company filings)

IRS No.: 043561634 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-50797 | Film No.: 181167287
SIC: 2836 Biological Products, (No Diagnostic Substances)
Assistant Director 1